Brilinta and Cholestyramine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Brilinta (ticagrelor) and Cholestyramine (cholestyramine). Common drug interactions include chronic kidney disease among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Brilinta and Cholestyramine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

What is Cholestyramine?

Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.

On Aug, 12, 2026

11 people who take Brilinta and Cholestyramine together, and have interactions are studied.

Brilinta and Cholestyramine drug interactions.

What are the common drug interactions of Brilinta and Cholestyramine, by gender? *:

female:

Chronic kidney disease
Renal failure (kidney dysfunction)
Dementia (madness)
Haemorrhage (bleeding)
Knee arthroplasty
Nephrogenic anaemia (anaemia due to kidney disease)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Pain
Photophobia (extreme sensitivity to light)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Pulmonary embolism (blockage of the main artery of the lung)
Chronic kidney disease
Dyspnoea (difficult or laboured respiration)
Dysstasia (difficulty in standing)
Emotional distress

What are the common drug interactions of Brilinta and Cholestyramine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Dysstasia (difficulty in standing)
Emotional distress
Gait disturbance
Pain

50-59:

n/a

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Nephrogenic anaemia (anaemia due to kidney disease)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Dyspnoea (difficult or laboured respiration)
Eye haemorrhage (bleeding in the eye)
Fluid retention (an abnormal accumulation of fluid in the blood)
Gallbladder disorder
Photophobia (extreme sensitivity to light)
Dementia (madness)

What are the existing conditions these people have? *

High Blood Cholesterol: 4 people, 36.36%
Pain: 3 people, 27.27%
Nausea (feeling of having an urge to vomit): 3 people, 27.27%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 18.18%
Blood Pressure Abnormal: 2 people, 18.18%
Hiv Infection: 2 people, 18.18%
Depression: 2 people, 18.18%
Diabetes: 2 people, 18.18%
Multiple Myeloma (cancer of the plasma cells): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Brilinta and Cholestyramine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously